N6-Methyladenosine Writer Gene ZC3H13 Predicts Immune Phenotype and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma
BackgroundAlthough the RNA modification N6-methyladenosine ZC3H13 has been found to play vital regulatory roles in many types of cancers, its role in predicting the tumor immune microenvironment (TME) and response to immune checkpoint blockade (ICB) in kidney renal clear cell carcinoma (KIRC) remain...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2021.718644/full |
id |
doaj-9307654b87704d01a2967555f43cf6c4 |
---|---|
record_format |
Article |
spelling |
doaj-9307654b87704d01a2967555f43cf6c42021-08-23T14:13:26ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-08-011110.3389/fonc.2021.718644718644N6-Methyladenosine Writer Gene ZC3H13 Predicts Immune Phenotype and Therapeutic Opportunities in Kidney Renal Clear Cell CarcinomaTao Guo0Hongxiang Duan1Jinbo Chen2Jinhui Liu3Belaydi Othmane4Jiao Hu5Huihuang Li6Xiongbing Zu7Department of Urology, Xiangya Hospital, Central South University, Changsha, ChinaSchool of Computer Science and Engineering, Central South University, Changsha, ChinaDepartment of Urology, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Urology, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Urology, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Urology, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Urology, Xiangya Hospital, Central South University, Changsha, ChinaDepartment of Urology, Xiangya Hospital, Central South University, Changsha, ChinaBackgroundAlthough the RNA modification N6-methyladenosine ZC3H13 has been found to play vital regulatory roles in many types of cancers, its role in predicting the tumor immune microenvironment (TME) and response to immune checkpoint blockade (ICB) in kidney renal clear cell carcinoma (KIRC) remains unclear.MethodsWe comprehensively analyzed the expression, prognostic significance and immunological role of ZC3H13 in pan-cancers and systematically correlated ZC3H13 with TME cell-infiltration, ICB response and targeted therapy in KIRC. The data were collected from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), Genotype-Tissue Expression (GTEx), Broad Institute Cancer Cell Line Encyclopedia (CCLE) and DrugBank database. Also, we performed RNA sequencing (RNA-seq) of 46 renal cell carcinoma tissues and 11 adjacent normal tissues to validate our result. All analyses were implemented using R software, version 3.6.3.ResultsZC3H13 was significantly differentially expressed in most tumors. However, its expression profiles and prognostic significance were consistent only in KIRC, regardless of overall survival, progression-free survival and cancer-specific survival. Additionally, ZC3H13 expression was correlated with clinicopathological factors in KIRC. Furthermore, we found that ZC3H13 might shape a noninflamed phenotype and could predict a lower response to ICB in KIRC. These results could be validated in our own RNA-seq data. Tumor mutation burden (TMB) was significantly higher in the low ZC3H13 group. Finally, we found that ZC3H13 could predict the sensitivity of targeted therapy for KIRC.ConclusionsZC3H13 might shape a noninflamed phenotype in KIRC. Moreover, ZC3H13 could predict the prognosis and clinical response of ICB and the sensitivity to targeted therapies in KIRC.https://www.frontiersin.org/articles/10.3389/fonc.2021.718644/fullZC3H13RNA modification N6-methyladenosinekidney renal clear cell carcinomatumor immune microenvironmentimmunotherapy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Tao Guo Hongxiang Duan Jinbo Chen Jinhui Liu Belaydi Othmane Jiao Hu Huihuang Li Xiongbing Zu |
spellingShingle |
Tao Guo Hongxiang Duan Jinbo Chen Jinhui Liu Belaydi Othmane Jiao Hu Huihuang Li Xiongbing Zu N6-Methyladenosine Writer Gene ZC3H13 Predicts Immune Phenotype and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma Frontiers in Oncology ZC3H13 RNA modification N6-methyladenosine kidney renal clear cell carcinoma tumor immune microenvironment immunotherapy |
author_facet |
Tao Guo Hongxiang Duan Jinbo Chen Jinhui Liu Belaydi Othmane Jiao Hu Huihuang Li Xiongbing Zu |
author_sort |
Tao Guo |
title |
N6-Methyladenosine Writer Gene ZC3H13 Predicts Immune Phenotype and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma |
title_short |
N6-Methyladenosine Writer Gene ZC3H13 Predicts Immune Phenotype and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma |
title_full |
N6-Methyladenosine Writer Gene ZC3H13 Predicts Immune Phenotype and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma |
title_fullStr |
N6-Methyladenosine Writer Gene ZC3H13 Predicts Immune Phenotype and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma |
title_full_unstemmed |
N6-Methyladenosine Writer Gene ZC3H13 Predicts Immune Phenotype and Therapeutic Opportunities in Kidney Renal Clear Cell Carcinoma |
title_sort |
n6-methyladenosine writer gene zc3h13 predicts immune phenotype and therapeutic opportunities in kidney renal clear cell carcinoma |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2021-08-01 |
description |
BackgroundAlthough the RNA modification N6-methyladenosine ZC3H13 has been found to play vital regulatory roles in many types of cancers, its role in predicting the tumor immune microenvironment (TME) and response to immune checkpoint blockade (ICB) in kidney renal clear cell carcinoma (KIRC) remains unclear.MethodsWe comprehensively analyzed the expression, prognostic significance and immunological role of ZC3H13 in pan-cancers and systematically correlated ZC3H13 with TME cell-infiltration, ICB response and targeted therapy in KIRC. The data were collected from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), Genotype-Tissue Expression (GTEx), Broad Institute Cancer Cell Line Encyclopedia (CCLE) and DrugBank database. Also, we performed RNA sequencing (RNA-seq) of 46 renal cell carcinoma tissues and 11 adjacent normal tissues to validate our result. All analyses were implemented using R software, version 3.6.3.ResultsZC3H13 was significantly differentially expressed in most tumors. However, its expression profiles and prognostic significance were consistent only in KIRC, regardless of overall survival, progression-free survival and cancer-specific survival. Additionally, ZC3H13 expression was correlated with clinicopathological factors in KIRC. Furthermore, we found that ZC3H13 might shape a noninflamed phenotype and could predict a lower response to ICB in KIRC. These results could be validated in our own RNA-seq data. Tumor mutation burden (TMB) was significantly higher in the low ZC3H13 group. Finally, we found that ZC3H13 could predict the sensitivity of targeted therapy for KIRC.ConclusionsZC3H13 might shape a noninflamed phenotype in KIRC. Moreover, ZC3H13 could predict the prognosis and clinical response of ICB and the sensitivity to targeted therapies in KIRC. |
topic |
ZC3H13 RNA modification N6-methyladenosine kidney renal clear cell carcinoma tumor immune microenvironment immunotherapy |
url |
https://www.frontiersin.org/articles/10.3389/fonc.2021.718644/full |
work_keys_str_mv |
AT taoguo n6methyladenosinewritergenezc3h13predictsimmunephenotypeandtherapeuticopportunitiesinkidneyrenalclearcellcarcinoma AT hongxiangduan n6methyladenosinewritergenezc3h13predictsimmunephenotypeandtherapeuticopportunitiesinkidneyrenalclearcellcarcinoma AT jinbochen n6methyladenosinewritergenezc3h13predictsimmunephenotypeandtherapeuticopportunitiesinkidneyrenalclearcellcarcinoma AT jinhuiliu n6methyladenosinewritergenezc3h13predictsimmunephenotypeandtherapeuticopportunitiesinkidneyrenalclearcellcarcinoma AT belaydiothmane n6methyladenosinewritergenezc3h13predictsimmunephenotypeandtherapeuticopportunitiesinkidneyrenalclearcellcarcinoma AT jiaohu n6methyladenosinewritergenezc3h13predictsimmunephenotypeandtherapeuticopportunitiesinkidneyrenalclearcellcarcinoma AT huihuangli n6methyladenosinewritergenezc3h13predictsimmunephenotypeandtherapeuticopportunitiesinkidneyrenalclearcellcarcinoma AT xiongbingzu n6methyladenosinewritergenezc3h13predictsimmunephenotypeandtherapeuticopportunitiesinkidneyrenalclearcellcarcinoma |
_version_ |
1721198291969900544 |